Table 1.
Characteristics of Cardiovascular Health Study Cohort Study at Baseline (N = 3 197)
| All | Women | Men | |
|---|---|---|---|
| N = 3 197 | N = 1 955 | N = 1 242 | |
| Count (%) | |||
| African American | 476 (15%) | 311 (16%) | 165 (13%)* |
| Current smoker | 294 (9%) | 187 (10%) | 107 (9%) |
| Ever drinks alcohol | 1 458 (46%) | 773 (40%) | 685 (55%)* |
| History of coronary heart disease | 664 (21%) | 327 (17%) | 337 (27%)* |
| History of congestive heart failure | 152 (5%) | 91 (5%) | 61 (5%) |
| Frequency of each event type in the composite outcome | |||
| Cancer | 284 (9%) | 153 (8%) | 131 (11%) |
| CVD | 464 (15%) | 274 (14%) | 190 (15%) |
| Dementia/MCI | 281 (9%) | 181 (9%) | 100 (8%) |
| Death | 684 (21%) | 343 (18%) | 341 (27%)* |
| Composite of death and diseases† | 1 267 (40%) | 707 (36%) | 560 (45%)* |
| Mean (standard deviation) | |||
| Age, y | 74 (5) | 74 (5) | 75 (5) |
| Physical activity, kcal/d | 1 104 (1 571) | 831 (1 146) | 1 533 (1 997)* |
| Body mass index, kg/m2 | 27 (5) | 27 (5) | 27 (4) |
| Waist circumference, cm | 97 (13) | 96 (15) | 99 (10)* |
| Alternate Healthy Eating Index | 3.0 (1.3) | 3.0 (1) | 2.8 (1.3)* |
| NT-proBNP, pg/mL | 307 (752) | 277 (597) | 354 (944)* |
| IL-6, pg/mL | 3.3 (2.2) | 3.2 (2.1) | 3.6 (2.3)* |
| IGF-1, µg/L | 98 (33) | 93 (32) | 107 (35)* |
| Cystatin-C, mg/L | 1.1 (0.3) | 1.1 (0.3) | 1.1 (0.3) |
| Insulin, mg/dL | 14 (22) | 14 (25) | 14 (19) |
| Fasting glucose, mg/dL | 107 (32) | 106 (32) | 109 (33)* |
| CRP, mg/L | 4.8 (7.3) | 5.1 (7.9) | 4.2 (6.2)* |
| TNFsR1, pg/mL | 1 488 (533) | 1 455 (504) | 1 540 (573) |
Notes: CVD = cardiovascular disease; CRP = C-reactive protein; IGF-1 = insulin-like growth factor-1; IL-6 = interleukin-6; MCI = mild cognitive impairment; NT-proBNP = N-terminal-proB-type natriuretic peptide; TNFsR1 = tumor necrosis factor alpha soluble receptor 1.
*The difference was statistically significant at a level of .05.
†The first occurrence of the composite of cancer, CVD, dementia, or MCI, or death.